Hedge Fund - Cormorant Asset Management

Bridgebio Pharma Inc. (BBIO) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q1 (2025-03-31) $69,140,000 5.2% 2,000,000 $33.72
2 2024 - Q4 (2024-12-31) $43,904,000 2.41% 1,600,000 $25.84
3 2024 - Q3 (2024-09-30) $47,313,616 2.5% 1,858,351 $26.25
4 2024 - Q2 (2024-06-30) $47,072,031 2.71% 1,858,351 $27.34
5 2024 - Q1 (2024-03-31) $99,037,657 4.34% 3,203,029 $34.01
6 2023 - Q4 (2023-12-31) $135,004,506 6.44% 3,344,179 $30.03
7 2023 - Q3 (2023-09-30) $122,950,916 7.17% 4,662,530 $28.38
8 2023 - Q2 (2023-06-30) $71,709,879 4.01% 4,169,179 $15.05
9 2023 - Q1 (2023-03-31) $75,562 4.97% 4,557,414 $11.66
10 2022 - Q4 (2022-12-31) $10,433 0.69% 1,369,179 $9.57
11 2022 - Q3 (2022-09-30) $14,604,000 1.02% 1,469,179 $10.39
12 2022 - Q2 (2022-06-30) $13,340,000 1% 1,469,179 $8.36
13 2022 - Q1 (2022-03-31) $15,924,000 1.22% 1,568,909 $10.26
14 2021 - Q4 (2021-12-31) $27,837,000 1.65% 1,668,909 $42.31
15 2021 - Q3 (2021-09-30) $82,909,000 3.36% 1,768,909 $53.60
16 2021 - Q2 (2021-06-30) $114,665,000 3.89% 1,880,980 $57.11
17 2021 - Q1 (2021-03-31) $133,605,000 2.97% 2,168,909 $65.42
18 2020 - Q4 (2020-12-31) $161,118,000 3.83% 2,265,762 $48.24
19 2020 - Q3 (2020-09-30) $85,011,000 3.26% 2,265,762 $31.46
20 2020 - Q2 (2020-06-30) $84,485,000 3.22% 2,590,762 $30.46
21 2020 - Q1 (2020-03-31) $85,550,000 3.97% 2,950,000 $31.01
22 2019 - Q4 (2019-12-31) $88,076,000 3.51% 2,512,865 $27.72
23 2019 - Q3 (2019-09-30) $56,199,000 3.42% 2,617,566 $27.66
24 2019 - Q2 (2019-06-30) $75,000,000 4.3% 2,780,885 $27.26

The displayed share prices are average quarterly stock market prices.